[ad_1]
THE WHAT? Galderma is preparing for a US$2.3 billion IPO on the Swiss stock exchange, aiming to use most of the proceeds for debt repayment and refinancing. The company, with a history as a Nestlé and L’Oréal joint venture and later acquired by EQT, is valued at around US$20 billion.
THE DETAILS The company’s move to go public signals a recovering European IPO market, with Galderma’s growth in specialized skincare products and successful “blockbuster franchises” driving its decision. Despite a recent downturn in IPO proceeds in Europe, Galderma and other companies are moving forward with listing plans, indicating a potential market revival.
THE WHY? Galderma reported over US$4 billion in sales last year, a nearly 9% increase, with significant EBITDA, showcasing its industry leadership. The IPO involves selling shares, including those of existing investors, coordinated by major financial institutions, highlighting Galderma’s strategic growth and financial health.
[ad_2]